Niagen Bioscience Inc ( NAGE) - Key Metrics
NAGE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.38 | $0.01 | $0.03 | $0.03 |
| 2026Q1 | $0.39 | $0.08 | -$0.01 | -$0.02 |
| 2025Q4 | $0.43 | $0.05 | $0.01 | $0.01 |
| 2025Q3 | $0.37 | $0.05 | $0.04 | $0.04 |
| 2025Q2 | $0.39 | $0.05 | $0.02 | $0.01 |
NAGE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 79.75 |
| 2026Q1 | 0% | 13.94 |
| 2025Q4 | 0% | 30.40 |
| 2025Q3 | 0% | 40.64 |
| 2025Q2 | 0% | 79.18 |
NAGE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.06% | 0% |
| 2026Q1 | -0.36% | 0% |
| 2025Q4 | 0.12% | 0% |
| 2025Q3 | 0.43% | 0% |
| 2025Q2 | 0.10% | 0% |
NAGE
Price: $3.18
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 16.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 242.9 million